CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 


Casi Pharmaceuticals Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



CASI Net Cash Flow Margin (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Revenue Change 25.9 % 19.7 % 57.98 % 89.92 % 91.23 %
Seq. Revenue Change 19.13 % -5.4 % -1.05 % 12.89 % 13.26 %
Revenue In Millions $10.21 $8.57 $9.06 $9.16 $8.11
Net Cash Flow Margin - -121.28 % -104.23 % -157.48 % -89.14 %
Net Cash Flow Margin Total Ranking # 247 # # # #
Net Cash Flow In Millions $19.84 $-10.40 $-9.45 $-14.42 $-7.23
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 194.28 %, below company's average Net Cash Flow Margin.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 26 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 247.

CASI's Net Cash Flow Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 111
Overall # 247

Net Cash Flow Margin Statistics
High Average Low
7524459.91 % 1505110.97 % 7.75 %
(Jun 30 2018)   (Mar 31 2020)




Other Net Cash Flow Margin Profitability Ratios
CASI's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
CASI's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for CASI's Competitors
Net Cash Flow Margin Profit Margin for Casi Pharmaceuticals Inc 's Suppliers
Net Cash Flow Margin Profit Margin for CASI's Customers

You may also want to know
CASI's Annual Growth Rates CASI's Profitability Ratios CASI's Asset Turnover Ratio CASI's Dividend Growth
CASI's Roe CASI's Valuation Ratios CASI's Financial Strength Ratios CASI's Net Cash Flow Growth
CASI's Roa CASI's Inventory Turnover Ratio CASI's Growth Rates CASI's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginSep 30 2022 MRQ Net Cash FlowSep 30 2022 MRQ Revenue
Orchard Therapeutics Plc  472.23 %$ 27.281 $ 5.777 
Pacific Biosciences Of California Inc   470.89 %$ 152.150 $ 32.311 
Precision Biosciences Inc  379.14 %$ 27.916 $ 7.363 
Aligos Therapeutics Inc   373.28 %$ 15.327 $ 4.106 
Tscan Therapeutics Inc   347.99 %$ 11.703 $ 3.363 
Ikena Oncology Inc   290.33 %$ 18.587 $ 6.402 
Agenus Inc  279.05 %$ 63.546 $ 22.772 
Sangamo Therapeutics Inc   231.17 %$ 61.167 $ 26.460 
Chase Corporation  219.00 %$ 192.894 $ 88.078 
Casi Pharmaceuticals inc   194.28 %$ 19.842 $ 10.213 
Fate Therapeutics Inc   179.01 %$ 26.818 $ 14.981 
United Health Products Inc   158.71 %$ 0.060 $ 0.038 
Surgalign Holdings Inc   108.75 %$ 21.943 $ 20.178 
Heska Corporation  83.99 %$ 51.646 $ 61.492 
Alector Inc   80.57 %$ 11.966 $ 14.852 
Pressure Biosciences Inc   75.89 %$ 0.109 $ 0.144 
Sutro Biopharma Inc   70.24 %$ 17.664 $ 25.147 
Neogen Corporation  47.32 %$ 62.625 $ 132.349 
Voyager Therapeutics Inc   45.10 %$ 18.531 $ 41.086 
Biogen Inc   43.11 %$ 1,081.300 $ 2,508.500 
Aerie Pharmaceuticals Inc   40.55 %$ 14.651 $ 36.129 
Telesis Bio Inc   39.46 %$ 2.634 $ 6.675 
Mymetics Corporation  39.23 %$ 0.057 $ 0.146 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GL's Profile

Stock Price

GL's Financials

Business Description

Fundamentals

Charts & Quotes

GL's News

Suppliers

GL's Competitors

Customers & Markets

Economic Indicators

GL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071